Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor

Seminars in Arthritis and Rheumatism

Volumn 29, Issue 2, 1999, Pages 82-99

  Hellmich, B ^a   Schnabel, A ^a   Gross, W L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Felty's syndrome; G CSF; GM CSF; Hematopoietic growth factors; Leukopenia; Neutropenia; Systemic lupus erythematosus

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTHRALGIA; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FELTY SYNDROME; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0032753199     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(99)80040-7     Document Type: Article

References (113)

1. Felty A.R. Chronic arthritis in the adult, associated with splenomegaly and leukopenia Bull Johns Hopkins Hosp 35 1924 16 24
2. Hanrahan E.M. Jr Miller S.R. The effect of splenectomy in Felty's syndrome JAMA 99 1932 1247 1249
3. Goeckerman W.H. Lupus erythematosus as a systemic disease JAMA 80 1923 542 547
4. Budman D.R. Steinberg A.S. Hematologic aspects of systemic lupus erythematosus Ann Intern Med 86 1977 220 229
5. Starkebaum G. Price T.H. Lee M.Y. Arend W.P. Autoimmune neutropenia in systemic lupus erythematosus Arthritis Rheum 21 1978 504 512
6. Breedveld F.C. Fibbe W.E. Herman J. van der Meer J. Cats A. Factors influencing the incidence of infections in Felty's syndrome Am J Med 147 1987 915 920
7. Keeling D.M. Isenberg D.A. Haematological manifestations of systemic lupus erythematosus Blood Rev 7 1993 199 207
8. Arenas M. Abad A. Valverde V. Ferriz P. Pascual R. Selective inhibition of granulopoesis with severe neutropenia in systemic lupus erythematosus Arthritis Rheum 35 1992 979 980
9. Clark R.A. Kimball H.R. Decker J.L. Neutrophil Chemotaxis in systemic lupus erythematosus Ann Rheum Dis 33 1974 167 172
10. Zurrier R.B. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus Arthritis Rheum 19 1976 73 78
11. Mowat A.G. Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis J Clin Invest 50 1971 2541 2549
12. Turner R.A. Schumacher H.R. Myers A.R. Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases J Clin Invest 52 1973 1632 1635
13. Allen L.S. Groff G. Treatment of Felty's syndrome with low dose methotrexate Arthritis Rheum 29 1986 902 905
14. Isai C. Lopez-Martin J.A. Trujiollo M.A. Andreu J.L. Palacio S. Mulero J. Felty's syndrome response to low dose methotrexate J Rheumatol 16 1989 983 985
15. Coiffier B. Cyclosporin in Felty's syndrome N Engl J Med 314 1986 184
16. Neish P.R. Fuchs H.A. Resolution of Felty's syndrome with cyclophosphamide J Rheumatol 16 1989 709 710
17. Dillon A.M. Luthra H.S. Conn D.L. Ferguson R.H. Parenteral gold therapy in Felty's syndrome Medicine 65 1986 107 112
18. Lakhanpal S. Luthra H.S. D-penicillamine in Felty's syndrome J Rheumatol 12 1985 703 706
19. Campion G. Maddison P.J. Goulding N. James I. Ahern M.J. Watt I. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serological features and immunogenetic associations Medicine 69 1990 69 80
20. Welte K. Gabrilove J. Bronchud M.H. Platzer E. Morstyn G. Filgrastim (r-met HuG-CSF): The first 10 years Blood 88 1996 1907 1929
21. Frampton J.E. Lee C.R. Faulds D. Filgrastim: a review of its pharmacological properties and therapeutic efficacy in neutropenia Drugs 48 1994 731 760
22. Anderlini P. Przepiorka D. Champlin R. Körbling M. Biological and clinical effects of granulocyte colony-stimulating factor in normal individuals Blood 88 1996 28l9 2825
23. Tan E.M. Cohen A.S. Fries J.F. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277
24. Bombardier C. Gladmann D.D. Urowitz M.B. Caron D. Chang C.H. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis studies in SLE Arthritis Rheum 35 1992 630 640
25. Lucas G.F. Prospective evaluation of the chemiluminiscence test for the detection of granulocyte antibodies: comparison with the granulocyteimmunofluorescence test Vox Sang 66 1994 141 147
26. Hartman K.R. Anti-neutrophil antibodies of the immunoglobulin M class in autoimmune neutropenia Am J Med Sci 308 1994 102 105
27. Tzioufas A.G. Kokori S.I. Petrovas C.I. Moutsopuolos H.M. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus Arthritis Rheum 40 1997 2212 2216
28. Goldschmeding R. Breedveld F.C. Engelfried C.P. von dem Borne A.E. Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty's syndrome Br J Hematol 68 1988 37 40
29. Rustagi P.K. Currie M.S. Logue G.L. Complementactivating anti-neutrophil antibody in systemic lupus erythematosus Am J Med 78 1985 971 977
30. Feng C.S. Ng M.H. Szeto R.S. Li E.K. Bone marrow findings in lupus patients with pancytopenia Pathology 23 1991 5 7
31. Rosenthal N.S. Farhi D.C. Bone marrow findings in connective tissue disease Am J Clin Pathol 92 1989 650 654
32. Yamasaki K. Niho Y. Yanase T. Granulopoesis in systemic lupus erythematosus Arthritis Rheum 26 1983 516 521
33. Metze I.L. Carvalho M.A. Costalat L.T. Bone marrow morphology in systemic lupus erythematosus Pathologe 15 1994 292 296
34. Liu H. Ozaki K. Matsuzaki Y. Abe M. Kosaka M. Saito S. Suppression of haematopoesis by IgG autoantibodies from patients with systemic lupus erythematosus Clin Exp Immunol 100 1995 480 485
35. Bailey F.A. Lilly M. Bertoli L.F. Ball G.V. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia Arthritis Rheum 32 1989 901 905
36. Starkebaum G. Singer J.W. Arend W.P. Humoral and cellular immune mechanisms of neutropenia in patients with Felt, 's syndrome Clin Exp Immunol 39 1980 307 314
37. Markusse H.M. Breedveld F.C. Fibbe W.E. Stern A.C. Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome Arthritis Rheum 33 1990 1865 1867
38. Abdou N.I. Heterogeneity of bone-marrow directed immune mechanisms in the pathogenesis of neutropenia in Felty's syndrome Arthritis Rheum 26 1983 947 953
39. Meliconi R. Uguccioni M. Chieco-Bianchi F. Pitzalis C. Bowman S. Facchini A. The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome Clin Exp Rheumatol 13 1995 285 291
40. Pixley J.S. Yoneda K.Y. Manalo P.B. Sequential administration of cyclophosphamide and colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome Am J Hematol 43 1993 304 306
41. Choi M.V. Mant M.J. Turner A.R. Akabutu J.J. Aaron S.L. Successful reversal of neutropenia in Felty's syndrome with recombinant granulocyte colony stimulating factor Br J Haematol 86 1994 663 664
42. Goldberg L.S. Bacon P.A. Bucknall R.C. Fitchen J. Cline M.J. Inhibition of human bone marrow-granulocyte precursors by serum from patients with Felty's syndrome J Rheumatol 7 1980 275 278
43. Rashba E.J. Rowe J.M. Packman C.H. Treatment of neutropenia of Felty's syndrome Blood Rev 10 1996 177 184
44. Frosch M. Roth J. Harms E. RhG-CSF resistant neutropenia in SLE Ann Rheum Dis 56 1997 396
45. Ruiz-Valverde M.P. Segarra A. Tovar J.L. Ribera R. Piera L. Treatment of severe leukopenia with rhG-CSF in systemic lupus erythematosus treated with cyclophosphamide Nephron 73 1996 715
46. Mant M.J. Akabum J.J. Herbert F.A. Lithium carbonate therapy in severe Felty's syndrome: benefits, toxicity and granulocyte function Arch Intern Med 146 1986 277 280
47. Clotet B. Argelagues E. Junca J. Plasmapheresis in Felty's syndrome Scand J Rheumatol 14 1985 438 441
48. Breedfeld F.C. Brand A. Van Aken W.G. High dose intravenous gammaglobulin for Felty's syndrome J Rheum 12 1985 700 702
49. Barnes C.G. Turnbull A.L. Vernon-Roberts B. Felty's syndrome: a clinical and pathologic survey of 21 patients and their response to treatment Ann Rheum Dis 30 1971 359 374
50. Moore R.A. Brunner C.M. Sandusky W.R. Leavell B.S. Felty's syndrome: long-term follow-up after splenectomy Ann Intern Med 75 1971 381 385
51. Ruderman M. Miller L.M. Pinals R.S. Clinical and serological observations on 27 patients with Felty's syndrome Arthritis Rheum 11 1968 377 384
52. Sienknecht C.W. Urowitz M.B. Pruzanski W. Stein H.B. Felty's syndrome: clinical and serological analysis of 34 cases Ann Rheum Dis 36 1977 500 507
53. Coon W.W. Splenectomy for cytopenias associated with systemic lupus erythematosus Am J Surg 155 1988 391 394
54. Welte K. Dale D. Pathophysiology and treatment of severe chronic neutropenia Ann Hematol 72 1996 158 165
55. Bishop N.J. Williams D.M. Compston J.C. Stirling D.M. Prentice A. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor Br J Haematol 89 1995 927 928
56. Freedman M.H. Safety of long-term administration of granulocyte colony-stimulating factor in the treatment of severe chronic neutropenia Curr Opin Hematol 4 1997 217 224
57. Bonilla M.A. Dale D. Zeidler C. Last L. Reiter A. Ruggeiro M. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias Br J Haematol 88 1994 723 730
58. Lyman G.H. Lyman C.G. Sanderson R.A. Balducci L. Decision analysis of hematopoetic growth factor use in patients receiving cancer chemotherapy J Natl Cancer Inst 85 1993 488
59. American Society of Clinical Oncology Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines J Clin Oncol 12 1994 2471 2508
60. Lieschke G.J. Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts) N Engl J Med 327 1991 28 35
61. Dale D.C. Hematopoietic growth factors for the treatment of severe chronic neutropenia Stems Cells 13 1995 94 100
62. Moore D.F. Vadhan-Raj S. Sustained response in Felty's syndrome to prolonged administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) Am J Med 98 1995 591 594
63. Fohlman J. Höglund M. Bergmann S. Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-CSF) Ann Hematol 69 1994 153 156
64. Joseph G. Neustadt D.H. Hamm J. Kellihan M. Hadley T. GM-CSF in treatment of Felty syndrome Am J Hematol 37 1991 55 56
65. Kaiser U. Klausmann M. Kolb G. Pflüger K.H. Havemann K. Felty's syndrome: favourable response to granulocytemacrophage colony-stimulating factor in the acute phase Acta Haematol 87 1992 190 194
66. Graham K.E. Coodley G.O. A prolonged use of granulocyte colony stimulating factor in Felty's syndrome J Rheumatol 22 1995 174 176
67. Hoshina Y. Moriuchi J. Nakamura Y. Arimori S. Ichikawa Y. CD4+ T cell-mediated leukopenia of Felty syndrome successfully treated with granulocyte-colony-stimulating factor and methotrexate Arthritis Rheum 37 1994 298 299
68. Del Pozo C. Sanchez L. Albero M.D. Arenas M.D. Prolonged treatment with granulocyte colony-stimulating factor in a patient with Felty's syndrome and chronic renal failure from secondary amyloidosis Nephrol Dial Transplant 12 1997 1727 1729
69. Marfeuille M. Clerc D. Mariette X. Successful treatment of agranulocytosis and sepsis with granulocyte colony stimulating factor in a case of Felty's syndrome J Rheumatol 22 1995 1803 1804
70. McMullin M.F. Finch M.B. Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash Clin Rheumatol 14 1995 204 208
71. Bhalla K. Ross R. Jeter E. Madyastha P. Stuart R. G-CSF improves granulocytopenia in Felty's syndrome without flare-up of arthritis Am J Hematol 42 1993 230 231
72. Wandt H. Seifert M. Falge C. Gallmeier W.M. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor Ann Hematol 66 1993 265 266
73. Hayat A.Q. Hearth-Holmes M. Wolf R.E. Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF) Clin Rheumatol 14 1995 211 212
74. Pereira J. Velloso E.D. Loteiro H.A. Laurindo I.M. Chamone D.A. Long-term remission of neutropenia in Felty's syndrome after short GM-CSF treatment Acta Haematol 92 1994 154 156
75. Nielsen N. Meier J. Remission of neutropenia in a case of Felty's syndrome by rhG-CSF Rheumatology 21 1991 305 307
76. Krishnaswamy G. Odem C. Chi D.S. Kalbfleisch J. Baker N. Smith J.K. Resolution of the neutropenia of Felty's syndrome by long-term administration of recombinant granulocyte colony stimulating factor J Rheumatol 23 1996 763 765
77. Wagner D.R. Combe C. Gresser U. GM-CSF and G-CSF in Felty's syndrome Clin Invest 71 1993 168 171
78. Lübbe A.S. Schwella N. Riess H. Huhn D. Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GMCSF) Blut 61 1990 379 380
79. Stanworth S.J. Bhavnani M. Chattopahya C. Miller H. Swinson D.R. Treatment of Felty's syndrome with hematopoietic growth factor granulocyte colony-stimulating factor (G-CSF) Q J Med 91 1998 49 56
80. Viddarson B. Geirsson A.J. Önundarson P.T. Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome Am J Med 98 1995 589 591
81. Yoshioka K. Combined therapy of G-CSF and prednisolone for neutropenia in a patient with Felty's syndrome Am J Hematol 48 1995 130 131
82. Farhey J.D. Herman J.H. Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome J Rheumatol 22 1995 1179 1181
83. Hailwood S.J. Harley L.J. Merry P. The use of granulocyte colony-stimulating factor in joint replacement surgery in a patient with Felty's syndrome Br J Rheumatol 36 1997 1232 1233
84. Hazemberg B.P. Van Leeuwen M.A. van Riijswijk M.H. Stern A.C. Vellenga E. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor: simultaneous induction of interleukin-6release and flare-up of the arthritis Blood 74 1989 2769 2773
85. Schots R. Verbruggen L.A. Demanet C. G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release Clin Rheumatol 14 1995 116 119
86. Kaiser U. Klausmann M. Richter G. Pflügler K.H. GMCSF versus G-CSF in the treatment of infectious complication in Felty's syndrome: a case report Ann Hematol 64 1992 205 206
87. Fraser D.D. Sartiano G. Butler T. Treadwell E.L. Neutropenia of Felty's syndrome successfully treated with granulocyte colony stimulating factor J Rheumatol 20 1993 1147 1148
88. (letter) Euler H.H. Schwab U.M. Schroeder J.O. Filgrastim for lupus neutropenia Lancet 344 1994 1513 1514
89. Schwab U.M. Harten P. Zeuner R.A. Külper M. Baler H.H. G-CSF bei patienten mit lupus-assoziierter leukopenie and infektionen Z Rheumatol 55 1996 174 179
90. Euler H.H. Harten P. Zeuner R.A. Schwab U.M. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractoryinfections J Rheumatol 24 1997 2153 2157
91. Yasuda M. Kihara T. Wada T. Granulocyte colonystimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient Arthritis Rheum 37 1994 145 146
92. Kondo H. Date Y. Sakai Y. Akimoto M. Effective simultaneous rhG-CSF and methylprednisolone pulse therapy in agranulocytosis associated with systemic lupus erythematosus Am J Hematol 46 1994 157 158
93. Ito T. Miyairi Y. Kuwabara T. Dan K. Nomura T. Granulocyte-colony stimulating factor corrects granulocytopenia in Felty's syndrome Am J Hematol 40 1992 318 319
94. Meropol N.J. Miller L.L. Korn E.L. Braitman L.E. MacDermot M.L. Schachter L.M. Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy J Natl Cancer Inst 84 1992 1201 1203
95. Lee M. Fukanaga R. Lee T. Lottsfeldt J. Nagata S. Bone modulation in sustained hematopoetic stimulation in mice Blood 77 1991 2135 2141
96. Sakamaki S. Matsunga T. Hirayama Y. Kuga T. Niitsu Y. Haematological study of healthy volunteers 5 years after G-CSF Lancet 346 1995 1432
97. Wun T. The Felty syndrome and G-CSF associated thrombocytopenia and severe anemia Ann Intern Med 118 1993 318 319
98. Shimoda K. Okamura S. Harada N. Kondo S. Okamura T. Niho Y. Indentification of a functional receptor for granulocyte colony-stimulating factor on platelets J Clin Invest 91 1993 1310 1313
99. Quesnel B. Catteau B. Aznar V. Bauters F. Fenaux P. Successful treatment of juvenile rheumatoid arthritis associated haemophagocytic syndrome with cyclosporine A with transient exacerbation by conventional dose G-CSF Br J Haematol 97 1997 508 510
100. Nakashima H. Horiuchi T. Kawabe K. Nagasawa K. Ohtsuka T. Niho Y. Rheumatoid arthritis exacerbation by G-CSF treatment for Bucillamine induced agranulocytosis Clin Exp Rheumatol 13 1995 677 679
101. Jain K.K. Cutaneous vasculitis associated with granulocyte colony-stimulating factor J Am Acad Dermatol 31 1994 213 215
102. Merkel P.A. Drugs associated with vasculitis Curr Opin Rheumatol 10 1998 45 50
103. Yong K.L. Linch D.C. Differential effects of granulocyte and granulocyte-macrophage colony-stimulating factor (G- and GM-CSF) on neutrophil adhesion in vitro and invivo Eur J Haematol 49 1992 251 259
104. De Haas M. Kerst J.M. van der Schot C.E. Calafat J. Hack C.E. Nuijens J.H. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating nentrophils Blood 84 1994 3885 3894
105. Spiekermann K. Rosler J. Emmendorfer A. Elsner J. Welte K. Functional features of nentrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications Leukemia 11 1997 466 478
106. Pollmdcher T. Korth C. Mullington J. Schreiber W. Sauer J. Vedder H. Effects of granulocyte colonystimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men Blood 86 1996 900 905
107. Hartung T. Döcke W.D. Gantner F. Krieger G. Sauer A. Stevens P. Effect of granulocyte colony stimulating factor treatment on ex vivo blood cytokine response in human volunteers Blood 85 1995 2482
108. Hoekman K. von Blomberg-van der Vlier B.M. Wagstaff J. Drexhage H.A. Pinedo H.M. Reversible thyroid dysfunction during treatment with GM-CSE Lancet 338 1991 541 542
109. Nathan F.E. Besa E.C. GM-CSF and accelerated hemolysis N Engl J Med 326 1992 417
110. Stehle B. Weiss C. Ho A.D. Hunstein W. Serum levels of tumor-necrosis factor a in patients treated with granulocytemacrophage colony-stimulating factor Blood 75 1990 1895 1896
111. Peters W.P. Shogan J. Shapall E.J. Jones R.B. Kim C.S. Recombinant human granulocyte-macrophage colony-stimulating factor produces fever Lancet 335 1988 950
112. Kurlander K. Immune nentropenia Rich R.R. Fleisher T.A. Shearer W.T. Schwartz B.D. Strober W. Clinical immunology principles and practice Vol. 2 1996 Mosby St Louis 1865 1869
113. Thorne C. Vrowitz M.B. Long-term outcome in Felty's syndrome Ann Rheum Dis 41 1982 486 489